Acutus Medical up on submission of data to FDA from heart device study
18/10/2022 17:42
** Acutus Medical Inc's shares AFIB.O rise 6.34% to $0.82
** Medical device maker submits data to US FDA for marketing
approval of its heart device to treat patients with irregular
heartbeat urn:newsml:reuters.com:*:nGNX50gPYK
** The data from the study demonstrated that the patients
using the heart device achieved clinically meaningful results
and also experienced no adverse events seven days after
procedure
** Including sessions gain, stock had fallen ~76% YTD
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on Acutus Medical
See all newsBrief: EnChannel Medical Signs Definitive Agreement To Acquire AcQMap Assets From Acutus Medical Inc
Brief: Acutus Medical, On April 30, Nasdaq Notified Co That It Has Not Regained Compliance With Listing Rule
Brief: Acutus Medical- Biotronik Sent A Notice Of Rescission And Termination To Company
Brief: Acutus Medical Says Co's Board Has Fixed Its Size At Six Members
U.S. STOCKS ON THE MOVE-Instacart, Nvidia, Novavax